Glucocorticoid sparing effect of zoledronic acid in sarcoid hypercalcemia

Authors:

Abstract
Glucocorticoids are regarded as first-line therapy in the management of hypercalcemia associated with sarcoidosis. However, prolonged glucocorticoid therapy leads to metabolic abnormalities, Cushingoid habitus, and impairment of bone health. This study demonstrates the efficacy and glucocorticoid-sparing effect of zoledronic acid in sarcoid hypercalcemia.

This publication has 13 references indexed in Scilit: